<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03104257</url>
  </required_header>
  <id_info>
    <org_study_id>1308012514</org_study_id>
    <secondary_id>1R01DA040698-01A1</secondary_id>
    <nct_id>NCT03104257</nct_id>
  </id_info>
  <brief_title>The Neural Correlates of Cannabis Use</brief_title>
  <acronym>Multimodal</acronym>
  <official_title>The Neural Correlates of Cannabis Use</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to determine the temporal course of recovery of CB1R&#xD;
      availability and neural oscillations, in cannabis-dependent individuals at baseline,&#xD;
      following 48 hour confirmed inpatient abstinence and after four weeks confirmed abstinence.&#xD;
      This research will also examine associations between CB1R availability, neural oscillations&#xD;
      and cognitive function.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this research study is to determine the temporal course of recovery of CB1R&#xD;
      availability and neural oscillations, in cannabis-dependent individuals at baseline,&#xD;
      following 48 hour confirmed inpatient abstinence and after four weeks confirmed outpatient&#xD;
      abstinence (confirmed by tracking creatinine adjusted urine THC-COOH levels). This research&#xD;
      will also examine associations between CB1R availability, neural oscillations and cognitive&#xD;
      function using [11-C]OMAR PET imaging and electroencephalography.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>CB1R availability using [11-C]OMAR PET imaging</measure>
    <time_frame>Change in CB1R availability from baseline to 48 hours and 28 days</time_frame>
    <description>Change in CB1R availability (e.g. volume distribution).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in Cognition during withdrawal using a computerized battery</measure>
    <time_frame>Change in CB1R availability from baseline to 48 hours and 28 days</time_frame>
    <description>Changes in cognitive functions such as attention, memory, motor functioning, and processing speed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in brain rhythms measured by Electroencephalography</measure>
    <time_frame>Change in CB1R availability from baseline to 48 hours and 28 days</time_frame>
    <description>Changes in electroencephalographic (EEG) brain rhythms related to information processing.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">37</enrollment>
  <condition>Cannabis Dependence</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Cannabis Dependent Subjects</arm_group_label>
    <description>Subjects who are frequent cannabis users</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Controls</arm_group_label>
    <description>Subjects with no current cannabis use</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>[11-C]OMAR</intervention_name>
    <description>The radiotracer, [11-C]OMAR will be administered at no more than 10 micrograms at the beginning of each PET scan.</description>
    <arm_group_label>Cannabis Dependent Subjects</arm_group_label>
    <arm_group_label>Healthy Controls</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      When specimens and information are stored, researchers are careful to try to protect your&#xD;
      identity from discovery by others. Samples and information will receive a unique code. Other&#xD;
      researchers will only receive coded samples and information, and will not be able to link the&#xD;
      code to subjects. Strict security safeguards are in place to reduce the chance of misuse or&#xD;
      unplanned release of information.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Research subjects can be both cannabis-using or non-cannabis using males and females&#xD;
        between the ages of 18-65.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: Cannabis Dependent Subjects&#xD;
&#xD;
          -  Current cannabis consumption&#xD;
&#xD;
          -  Willing to abstain from cannabis use for four weeks&#xD;
&#xD;
        Inclusion Criteria for Healthy Controls&#xD;
&#xD;
          -  No current cannabis consumption&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  MRI metal exclusions and claustrophobia&#xD;
&#xD;
          -  Education completed is less than 12 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick Skosnik, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick Skosnik, PhD</last_name>
    <phone>203-932-5711</phone>
    <phone_ext>2252</phone_ext>
    <email>patrick.skosnik@yale.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mohini Ranganathan, MD</last_name>
    <phone>203-932-5711</phone>
    <phone_ext>2546</phone_ext>
    <email>mohini.ranganathan@yale.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Conneticut Mental Health Center</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06519</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>203-974-7775</phone>
    </contact>
    <contact_backup>
      <phone>203-974-7489</phone>
    </contact_backup>
    <investigator>
      <last_name>Patrick Skosnik, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mohini Ranganathan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 22, 2016</study_first_submitted>
  <study_first_submitted_qc>March 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 7, 2017</study_first_posted>
  <last_update_submitted>January 8, 2021</last_update_submitted>
  <last_update_submitted_qc>January 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Healthy Control, Cannabis, Dependence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Marijuana Abuse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

